MedTrace Logo

Copd Exacerbation and Pulmonary Hypertension Trial

NCT04538976 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2025-03-13

No results posted yet for this study

Summary

This trial will investigate whether patiens admitted with an acute exacerbation of chronic obstructive lung disease and pulmonary hypertension will benefit from a targeted pharmacological treatment.

Conditions

  • Acute Exacerbation of COPD

Interventions

DRUG

Sildenafil

Sildenafil in standard dosage

Sponsors & Collaborators

  • Chronic Obstructive Pulmonary Disease Trial Network, Denmark

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-01
Primary Completion
2024-03-15
Completion
2024-03-15

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04538976 on ClinicalTrials.gov